BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang X, Jiang F, Wang X, Xia Y, Mao Y, Chen Y. Identification of the Ferroptosis-Related Long Non-Coding RNAs Signature to Improve the Prognosis Prediction in Papillary Renal Cell Carcinoma. Front Surg 2022;9:741726. [DOI: 10.3389/fsurg.2022.741726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xie W, Gu J, Qin Z, Xie Y. The Roles of Ferroptosis-related Long Non-coding RNAs in Urologic Cancers. ann urol oncol 2023. [DOI: 10.32948/auo.2023.01.20] [Reference Citation Analysis]
2 Jiang K, Wu L, Yin X, Tang Q, Yin J, Zhou Z, Yu H, Yan S. Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1036098] [Reference Citation Analysis]
3 Shi W, Liu Y, Qiu X, Zhou J, Zhou J, Lin G. Construction and validation of a novel Ferroptosis-related gene signature predictive model in rectal Cancer. BMC Genomics 2022;23:764. [DOI: 10.1186/s12864-022-08996-6] [Reference Citation Analysis]
4 Sun M, Qi S, Wu M, Xia W, Xiong H. Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma. Front Genet 2022;13:909556. [DOI: 10.3389/fgene.2022.909556] [Reference Citation Analysis]
5 Zhang X, Qin X, Yu T, Wang K, Chen Y, Xing Q. Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation. Front Genet 2022;13:974726. [DOI: 10.3389/fgene.2022.974726] [Reference Citation Analysis]
6 Yan L, Chen X, Bian Z, Gu C, Ji H, Chen L, Xu H, Tang Q. A ferroptosis associated gene signature for predicting prognosis and immune responses in patients with colorectal carcinoma. Front Genet 2022;13:971364. [DOI: 10.3389/fgene.2022.971364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yan X, Wang N, Dong J, Wang F, Zhang J, Hu X, Zhao H, Gao X, Liu Z, Li Y, Hu S. A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma. Front Mol Biosci 2022;9:966843. [DOI: 10.3389/fmolb.2022.966843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang G, Sun J, Zhang X. A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma. Sci Rep 2022;12:11325. [PMID: 35790864 DOI: 10.1038/s41598-022-15251-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
9 Trevisani F, Floris M, Vago R, Minnei R, Cinque A. Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge? Cells 2022;11:1658. [PMID: 35626699 DOI: 10.3390/cells11101658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]